Hereditary colorectal cancer diagnostics: morphological features of familial colorectal cancer type X versus Lynch syndrome
- 1Clinical Research Centre, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark
- 2Department of Pathology, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark
- 3HNPCC Register, Department of Gastroenterology, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark
- 4Department of Oncology, Institute of Clinical Sciences, Lund University, Lund, Sweden
- Correspondence to Louise Klarskov, Department of Pathology, Hillerød Hospital, DK-3400 Hillerød, Denmark;
- Accepted 22 December 2011
- Published Online First 28 January 2012
Background The hereditary non-polyposis colorectal cancer (HNPCC) subset of tumours can broadly be divided into tumours caused by an underlying mismatch-repair gene mutation, referred to as Lynch syndrome, and those that develop in families with similar patterns of heredity but without disease-predisposing germline mismatch repair mutations, referred to as familial colorectal cancer type X (FCCTX). Recognition of HNPCC-associated colorectal cancers is central since surveillance programmes effectively reduce morbidity and mortality. The characteristic morphological features linked to Lynch syndrome can aid in the identification of this subset, whereas the possibility to use morphological features as an indicator of FCCTX is uncertain.
Objective and methods To perform a detailed morphological evaluation of HNPCC-associated colorectal cancers and demonstrate significant differences between tumours associated with FCCTX and Lynch syndrome.
Results The morphological features associated with Lynch syndrome, that is, right-sided tumour location, poor differentiation, expansive growth pattern, tumour-infiltrating lymphocytes, peritumorous lymphocytes, Crohn-like reactions, and lack of dirty necrosis, were significantly less often observed in FCCTX tumours.
Discussion The less typical morphology in FCCTX implies that family history of cancer needs to be taken into account since these tumours cannot readily be recognised based on histopathological features.
- Colorectal carcinoma
- colorectal cancer
- familial cancers
Funding Financial support was from the Danish Cancer Society, the Lundbeck Foundation and the Hvidovre University Hospital.
Competing interests None.
Ethics approval Ethics approval was provided by the scientific ethical committee of Region Hovedstaden, Denmark.
Provenance and peer review Not commissioned; externally peer reviewed.